Literature DB >> 7779714

Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted by phenobarbital.

A Bishayee1, M Chatterjee.   

Abstract

The chemoprotective effect of vanadium, a dietary micronutrient, against chemically induced hepatocarcinogenesis in rats was investigated. Initiation was performed by a single intraperitoneal injection of diethylnitrosamine (DENA; 200 mg kg-1) followed by promotion with phenobarbital (0.05%) in the diet. Supplementary vanadium (0.5 p.p.m.) in the drinking water was provided ad libitum throughout the experiment, before the initiation or during the promotion period. At the end of the study (20 weeks), vanadium supplementation throughout the experiment reduced the incidence (P < 0.01), total number and multiplicity (P < 0.001) and altered the size distribution of visible persistent nodules (PNs) as compared with DENA control animals. Mean nodular volume (P < 0.05) and nodular volume as a percentage of liver volume (P < 0.01) were also attenuated following long-term vanadium treatment. It also caused a large decrease in the number (P < 0.001) and surface area (P < 0.01) of gamma-glutamyltranspeptidase (GGT)-positive hepatocyte foci and in the labelling index (P < 0.001) of focal cells, coupled with increased (P < 0.01) remodelling. The activity of GGT, measured quantitatively, was found to be significantly less in the PNs (P < 0.001) and non-nodular surrounding parenchyma (P < 0.01) of vanadium-supplemented rats. The anticarcinogenic effect of vanadium was also reflected in the histopathological analysis of liver sections that showed a well-maintained hepatocellular architecture as compared with DENA control. Similar results were observed when vanadium was given only before the initiation. However, supplementation of vanadium during the promotion period did not result in significant alterations of these parameters. Our results, thus, strongly suggest that vanadium may have a unique anti-tumour potential which is primarily exerted on the initiation phase and only secondarily on the promotion stage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779714      PMCID: PMC2033852          DOI: 10.1038/bjc.1995.236

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  44 in total

Review 1.  The sequential analysis of cancer development.

Authors:  E Farber; R Cameron
Journal:  Adv Cancer Res       Date:  1980       Impact factor: 6.242

2.  The multistep nature of cancer development.

Authors:  E Farber
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

Review 3.  The stages of initiation and promotion in hepatocarcinogenesis.

Authors:  H C Pitot; A E Sirica
Journal:  Biochim Biophys Acta       Date:  1980-05-06

4.  Activation by chemical carcinogens of gamma-glutamyl transpeptidase in rat and mouse liver.

Authors:  S Fiala; E S Fiala
Journal:  J Natl Cancer Inst       Date:  1973-07       Impact factor: 13.506

5.  Interaction of gamma-glutamyl transpeptidase with amino acids, dipeptides, and derivatives and analogs of glutathione.

Authors:  S S Tate; A Meister
Journal:  J Biol Chem       Date:  1974-12-10       Impact factor: 5.157

Review 6.  Cellular biochemistry of the stepwise development of cancer with chemicals: G. H. A. Clowes memorial lecture.

Authors:  E Farber
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

7.  Nitrosamines as environmental carcinogens. II. Evidence for the presence of nitrosamines in tobacco smoke condensate.

Authors:  W J Serfontein; P Hurter
Journal:  Cancer Res       Date:  1966-04       Impact factor: 12.701

8.  Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver.

Authors:  H A Campbell; H C Pitot; V R Potter; B A Laishes
Journal:  Cancer Res       Date:  1982-02       Impact factor: 12.701

9.  Dietary vanadyl(IV) sulfate inhibits chemically-induced mammary carcinogenesis.

Authors:  H J Thompson; N D Chasteen; L D Meeker
Journal:  Carcinogenesis       Date:  1984-06       Impact factor: 4.944

10.  Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver.

Authors:  M Tatematsu; Y Nagamine; E Farber
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

View more
  13 in total

1.  Chemopreventive effect of vanadium in a rodent model of chemical hepatocarcinogenesis: reflections in oxidative DNA damage, energy-dispersive X-ray fluorescence profile and metallothionein expression.

Authors:  Tridib Chakraborty; Amrita Chatterjee; Mahesh G Saralaya; Malay Chatterjee
Journal:  J Biol Inorg Chem       Date:  2006-07-08       Impact factor: 3.358

2.  Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms.

Authors:  Anupam Bishayee; Deepak Bhatia; Roslin J Thoppil; Altaf S Darvesh; Eviatar Nevo; Ephraim P Lansky
Journal:  Carcinogenesis       Date:  2011-03-09       Impact factor: 4.944

3.  Effect of vanadium on colonic aberrant crypt foci induced in rats by 1,2 dimethyl hydrazine.

Authors:  P-Suresh Kanna; C B Mahendrakumar; T Chakraborty; P Hemalatha; Pratik Banerjee; M Chatterjee
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

4.  Chemopreventive potential of Epoxy clerodane diterpene from Tinospora cordifolia against diethylnitrosamine-induced hepatocellular carcinoma.

Authors:  Muniyappan Dhanasekaran; Arul-Albert Baskar; Savarimuthu Ignacimuthu; Paul Agastian; Veeramuthu Duraipandiyan
Journal:  Invest New Drugs       Date:  2008-10-14       Impact factor: 3.850

5.  1alpha, 25-dihydroxyvitamin D3 prevents DNA damage and restores antioxidant enzymes in rat hepatocarcinogenesis induced by diethylnitrosamine and promoted by phenobarbital.

Authors:  Mahendrakumar Chandrasekharappa Banakar; Suresh Kanna Paramasivan; Mitali Basu Chattopadhyay; Subrata Datta; Prabir Chakraborty; Malay Chatterjee; Kalaiselvi Kannan; Elayaraja Thygarajan
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

6.  Inhibition of DNA alkylation damage with inorganic salts.

Authors:  Elizabeth E Hamilton; Jonathan J Wilker
Journal:  J Biol Inorg Chem       Date:  2004-09-16       Impact factor: 3.358

7.  Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma.

Authors:  Daniel J Luther; Vahagn Ohanyan; Patricia E Shamhart; Cheryl M Hodnichak; Hamayak Sisakian; Tristan D Booth; J Gary Meszaros; Anupam Bishayee
Journal:  Invest New Drugs       Date:  2009-10-08       Impact factor: 3.850

8.  Protective effects of garlic oil on hepatocarcinoma induced by N-nitrosodiethylamine in rats.

Authors:  Cui-Li Zhang; Tao Zeng; Xiu-Lan Zhao; Li-Hua Yu; Zhen-Ping Zhu; Ke-Qin Xie
Journal:  Int J Biol Sci       Date:  2012-02-22       Impact factor: 6.580

9.  Proton-Induced X-ray Emission (PIXE) Analysis and DNA-chain Break study in rat hepatocarcinogenesis: A possible chemopreventive role by combined supplementation of vanadium and beta-carotene.

Authors:  Mitali Basu Chattopadhyay; Sutapa Mukherjee; Indira Kulkarni; V Vijayan; Manika Doloi; Nb Kanjilal; Malay Chatterjee
Journal:  Cancer Cell Int       Date:  2005-05-26       Impact factor: 5.722

10.  Resveratrol down-regulates Myosin light chain kinase, induces apoptosis and inhibits diethylnitrosamine-induced liver tumorigenesis in rats.

Authors:  Xiao-Lin Zhang; Hao Yu; You-Yi Xiong; Shi-Tang Ma; Lei Zhao; Shi-Feng She
Journal:  Int J Mol Sci       Date:  2013-01-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.